DE | EN

Neueste Nachrichten

01/06/2012
Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution + read

VITA 34 AG

VITA 34 was founded in 1997 as the first private umbilical cord blood bank in Europe. VITA 34 has been focusing on the long-term storage of umbilical cord blood and the production of stem cell transplants of the highest quality and safety. The aim is to develop into a leading provider of cell products in the field of regenerative medicine. With multiple subsidiaries or partners VITA 34 is employed outside Germany, eg Spain, Italy, Austria, Switzerland, Slovenia and Slovakia.

to top